{
    "root": "35d3eb43-c6ef-f3ab-e063-6294a90a0891",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Zyclara",
    "value": "20250523",
    "ingredients": [
        {
            "name": "ISOSTEARIC ACID",
            "code": "X33R8U0062"
        },
        {
            "name": "CETYL ALCOHOL",
            "code": "936JST6JCN"
        },
        {
            "name": "STEARYL ALCOHOL",
            "code": "2KR89I4H1Y"
        },
        {
            "name": "PETROLATUM",
            "code": "4T6H12BN9U"
        },
        {
            "name": "POLYSORBATE 60",
            "code": "CAL22UVI4M"
        },
        {
            "name": "SORBITAN MONOSTEARATE",
            "code": "NVZ4I0H58X"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "XANTHAN GUM",
            "code": "TTV12P4NEE"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "IMIQUIMOD",
            "code": "P1QW714R7M"
        }
    ],
    "indications": "ZYCLARA 2.5% and 3.75% is indicated for the topical treatment of clinically typical, visible, or palpable actinic keratoses (AK) of the face or balding scalp in immunocompetent adults. ( 1.1 ) ZYCLARA, 3.75% is indicated for the topical treatment of external genital and perianal warts (EGW) in immunocompetent patients 12 years of age or older. ( 1.2 )",
    "contraindications": "For topical use only; not for oral, ophthalmic, intra-anal or intravaginal use. ( 2.1 ) AK : Apply a thin layer once daily at bedtime to affected area (either entire face or balding scalp) for two 2-week treatment cycles separated by a 2-week no-treatment period. Apply up to 0.5 grams at each application. ( 2.2 ) EGW : Apply a thin layer once daily at bedtime until total clearance or up to 8 weeks. Apply up to 0.25 grams at each application. ( 2.3 )",
    "warningsAndPrecautions": "How Supplied\n                  \n                  ZYCLARA (imiquimod) cream is white to faintly yellow in color.\n                  ZYCLARA, 2.5% and 3.75% is supplied as white plastic 30 mL pump bottles, equipped with a white cap. The 7.5 g pump bottle delivers no fewer than 28 full actuations:\n                  \n                     2.5% cream, NDC 99207-276-75\n                     3.75% cream, NDC 99207-271-75\n                  \n                  ZYCLARA, 3.75% is also supplied in unit-dose plastic laminate packets which contain 0.25 g of cream:\n                  \n                     3.75% cream, box of 28 packets, NDC 99207-270-28",
    "adverseReactions": "None."
}